{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:47:57Z","timestamp":1782103677712,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA229811"],"award-info":[{"award-number":["CA229811"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA229811"],"award-info":[{"award-number":["CA229811"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA229811"],"award-info":[{"award-number":["CA229811"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA229811"],"award-info":[{"award-number":["CA229811"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA229811"],"award-info":[{"award-number":["CA229811"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA229811"],"award-info":[{"award-number":["CA229811"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA229811"],"award-info":[{"award-number":["CA229811"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA229811"],"award-info":[{"award-number":["CA229811"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA229811"],"award-info":[{"award-number":["CA229811"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA229811"],"award-info":[{"award-number":["CA229811"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA229811"],"award-info":[{"award-number":["CA229811"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA229811"],"award-info":[{"award-number":["CA229811"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA229811"],"award-info":[{"award-number":["CA229811"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA229811"],"award-info":[{"award-number":["CA229811"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02293-w","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T15:15:26Z","timestamp":1777734926000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi\u2011scale immune and spatial profiling of sclerosing adenosis and surrounding breast tissue identifies an immune\u2011cold field phenotype associated with breast cancer risk"],"prefix":"10.1186","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7511-6169","authenticated-orcid":false,"given":"Nicole","family":"Cruz-Reyes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongling","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melody","family":"Stallings-Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pacheco-Spann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan M.","family":"McCauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Vierkant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denice L.","family":"Gehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Degnim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey J.","family":"Winham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1962-8784","authenticated-orcid":false,"given":"Derek C.","family":"Radisky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"2293_CR1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2147\/IJWH.S351095","volume":"15","author":"JL Fraker","year":"2023","unstructured":"Fraker JL, Clune CG, Sahni SK, Yaganti A, Vegunta S. Prevalence, impact, and diagnostic challenges of benign breast disease: a narrative review. Int J Womens Health. 2023;15:765\u201378.","journal-title":"Int J Womens Health"},{"key":"2293_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13058-021-01410-1","volume":"23","author":"JD Figueroa","year":"2021","unstructured":"Figueroa JD, Gierach GL, Duggan MA, Fan S, Pfeiffer RM, Wang Y, Falk RT, Loudig O, Abubakar M, Ginsberg M, et al. Risk factors for breast cancer development by tumor characteristics among women with benign breast disease. Breast Cancer Res. 2021;23:34.","journal-title":"Breast Cancer Res"},{"key":"2293_CR3","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/1097-0142(19891115)64:10<1977::AID-CNCR2820641002>3.0.CO;2-N","volume":"64","author":"RA Jensen","year":"1989","unstructured":"Jensen RA, Page DL, Dupont WD, Rogers LW. Invasive breast cancer risk in women with sclerosing adenosis. Cancer. 1989;64:1977\u201383.","journal-title":"Cancer"},{"key":"2293_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10549-014-2862-5","volume":"144","author":"DW Visscher","year":"2014","unstructured":"Visscher DW, Nassar A, Degnim AC, Frost MH, Vierkant RA, Frank RD, Tarabishy Y, Radisky DC, Hartmann LC. Sclerosing adenosis and risk of breast cancer. Breast Cancer Res Treat. 2014;144:205\u201312.","journal-title":"Breast Cancer Res Treat"},{"key":"2293_CR5","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/jnci\/djhs105","volume":"96","author":"J Wang","year":"2004","unstructured":"Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N. Lower-category benign breast disease and the risk of invasive breast cancer. J Natl Cancer Inst. 2004;96:616\u201320.","journal-title":"J Natl Cancer Inst"},{"key":"2293_CR6","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/1097-0142(19920315)69:6<1408::AID-CNCR2820690617>3.0.CO;2-C","volume":"69","author":"RW McDivitt","year":"1992","unstructured":"McDivitt RW, Stevens JA, Lee NC, Wingo PA, Rubin GL, Gersell D. Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group. Cancer. 1992;69:1408\u201314.","journal-title":"Cancer"},{"key":"2293_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa044383","volume":"353","author":"LC Hartmann","year":"2005","unstructured":"Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353:229\u201337.","journal-title":"N Engl J Med"},{"key":"2293_CR8","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1200\/JCO.2014.55.4865","volume":"33","author":"VS Pankratz","year":"2015","unstructured":"Pankratz VS, Degnim AC, Frank RD, Frost MH, Visscher DW, Vierkant RA, Hieken TJ, Ghosh K, Tarabishy Y, Vachon CM, et al. Model for individualized prediction of breast cancer risk after a benign breast biopsy. J Clin Oncol. 2015;33:923\u20139.","journal-title":"J Clin Oncol"},{"key":"2293_CR9","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1002\/cncr.31528","volume":"124","author":"RD Frank","year":"2018","unstructured":"Frank RD, Winham SJ, Vierkant RA, Frost MH, Radisky DC, Ghosh K, Brandt KR, Sherman ME, Visscher DW, Hartmann LC, et al. Evaluation of 2 breast cancer risk models in a benign breast disease cohort. Cancer. 2018;124:3319\u201328.","journal-title":"Cancer"},{"key":"2293_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41523-024-00703-w","volume":"11","author":"A Burke","year":"2025","unstructured":"Burke A, O\u2019Driscoll J, Abubakar M, Bennett KE, Carmody E, Flanagan F, Gierach GL, Mullooly M. A systematic review of determinants of breast cancer risk among women with benign breast disease. NPJ Breast Cancer. 2025;11:16.","journal-title":"NPJ Breast Cancer"},{"key":"2293_CR11","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1200\/JCO.2009.23.4120","volume":"28","author":"K Ghosh","year":"2010","unstructured":"Ghosh K, Hartmann LC, Reynolds C, Visscher DW, Brandt KR, Vierkant RA, Scott CG, Radisky DC, Sellers TA, Pankratz VS, et al. Association between mammographic density and age-related lobular involution of the breast. J Clin Oncol. 2010;28:2207\u201312.","journal-title":"J Clin Oncol"},{"key":"2293_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13058-017-0922-6","volume":"19","author":"K Ghosh","year":"2017","unstructured":"Ghosh K, Vierkant RA, Frank RD, Winham S, Visscher DW, Pankratz VS, Scott CG, Brandt K, Sherman ME, Radisky DC, et al. Association between mammographic breast density and histologic features of benign breast disease. Breast Cancer Res. 2017;19:134.","journal-title":"Breast Cancer Res"},{"key":"2293_CR13","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/jnci\/djt124","volume":"105","author":"JA Tice","year":"2013","unstructured":"Tice JA, O\u2019Meara ES, Weaver DL, Vachon C, Ballard-Barbash R, Kerlikowske K. Benign breast disease, mammographic breast density, and the risk of breast cancer. J Natl Cancer Inst. 2013;105:1043\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"2293_CR14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10549-016-3691-5","volume":"155","author":"DC Radisky","year":"2016","unstructured":"Radisky DC, Visscher DW, Frank RD, Vierkant RA, Winham S, Stallings-Mann M, Hoskin TL, Nassar A, Vachon CM, Denison LA, et al. Natural history of age-related lobular involution and impact on breast cancer risk. Breast Cancer Res Treat. 2016;155:423\u201330.","journal-title":"Breast Cancer Res Treat"},{"key":"2293_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1001\/jamasurg.2023.6382","volume":"159","author":"ME Sherman","year":"2024","unstructured":"Sherman ME, Vierkant RA, Winham SJ, Vachon CM, Carter JM, Pacheco-Spann L, Jensen MR, McCauley BM, Hoskin TL, Seymour L, et al. Benign breast disease and breast cancer risk in the percutaneous biopsy era. JAMA Surg. 2024;159:193\u2013201.","journal-title":"JAMA Surg"},{"key":"2293_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4161\/onci.18614","volume":"1","author":"S Mahmoud","year":"2012","unstructured":"Mahmoud S, Lee A, Ellis I, Green A. CD8(+) T lymphocytes infiltrating breast cancer: a promising new prognostic marker? Oncoimmunology. 2012;1:364\u20135.","journal-title":"Oncoimmunology"},{"key":"2293_CR17","doi-asserted-by":"publisher","first-page":"101134","DOI":"10.1016\/j.eclinm.2021.101134","volume":"41","author":"F Li","year":"2021","unstructured":"Li F, Li C, Cai X, Xie Z, Zhou L, Cheng B, Zhong R, Xiong S, Li J, Chen Z, et al. The association between CD8\u2009+\u2009tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: a systematic review and meta-analysis. EClinicalMedicine. 2021;41:101134.","journal-title":"EClinicalMedicine"},{"key":"2293_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3892\/ol.2022.13625","volume":"25","author":"YP Sun","year":"2023","unstructured":"Sun YP, Ke YL, Li X. Prognostic value of CD8(+) tumor-infiltrating T cells in patients with breast cancer: a systematic review and meta-analysis. Oncol Lett. 2023;25:39.","journal-title":"Oncol Lett"},{"key":"2293_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10549-022-06787-x","volume":"197","author":"S Yazaki","year":"2023","unstructured":"Yazaki S, Shimoi T, Yoshida M, Sumiyoshi-Okuma H, Arakaki M, Saito A, Kita S, Yamamoto K, Kojima Y, Nishikawa T, et al. Integrative prognostic analysis of tumor-infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy. Breast Cancer Res Treat. 2023;197:287\u201397.","journal-title":"Breast Cancer Res Treat"},{"key":"2293_CR20","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/j.immuni.2024.06.017","volume":"57","author":"NV Gavil","year":"2024","unstructured":"Gavil NV, Cheng K, Masopust D. Resident memory T cells and cancer. Immunity. 2024;57:1734\u201351.","journal-title":"Immunity"},{"key":"2293_CR21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ccell.2023.01.004","volume":"41","author":"B Virassamy","year":"2023","unstructured":"Virassamy B, Caramia F, Savas P, Sant S, Wang J, Christo SN, Byrne A, Clarke K, Brown E, Teo ZL, et al. Intratumoral CD8(+) T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer. Cancer Cell. 2023;41:585\u2013e601588.","journal-title":"Cancer Cell"},{"key":"2293_CR22","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41591-018-0078-7","volume":"24","author":"P Savas","year":"2018","unstructured":"Savas P, Virassamy B, Ye C, Salim A, Mintoff CP, Caramia F, Salgado R, Byrne DJ, Teo ZL, Dushyanthen S, et al. Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis. Nat Med. 2018;24:986\u201393.","journal-title":"Nat Med"},{"key":"2293_CR23","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1158\/1078-0432.CCR-16-2026","volume":"23","author":"AC Degnim","year":"2017","unstructured":"Degnim AC, Hoskin TL, Arshad M, Frost MH, Winham SJ, Brahmbhatt RA, Pena A, Carter JM, Stallings-Mann ML, Murphy LM, et al. Alterations in the immune cell composition in premalignant breast tissue that precede breast cancer development. Clin Cancer Res. 2017;23:3945\u201352.","journal-title":"Clin Cancer Res"},{"key":"2293_CR24","doi-asserted-by":"crossref","unstructured":"Egelston CA, Avalos C, Tu TY, Rosario A, Wang R, Solomon S, Srinivasan G, Nelson MS, Huang Y, Lim MH et al. Resident memory CD8\u2009+\u2009T cells within cancer islands mediate survival in breast cancer patients. JCI Insight 2019, 4.","DOI":"10.1172\/jci.insight.130000"},{"key":"2293_CR25","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1016\/j.clbc.2020.06.011","volume":"21","author":"SL Goff","year":"2021","unstructured":"Goff SL, Danforth DN. The role of immune cells in breast tissue and immunotherapy for the treatment of breast cancer. Clin Breast Cancer. 2021;21:e63\u201373.","journal-title":"Clin Breast Cancer"},{"key":"2293_CR26","doi-asserted-by":"crossref","unstructured":"Okla K, Farber DL, Zou W. Tissue-resident memory T cells in tumor immunity and immunotherapy. J Exp Med 2021, 218.","DOI":"10.1084\/jem.20201605"},{"key":"2293_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10549-019-05493-5","volume":"180","author":"S Adhikary","year":"2020","unstructured":"Adhikary S, Hoskin TL, Stallings-Mann ML, Arshad M, Frost MH, Winham SJ, Pena A, Lee DJ, Murphy LM, Rakoff M, et al. Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast disease. Breast Cancer Res Treat. 2020;180:55\u201361.","journal-title":"Breast Cancer Res Treat"},{"key":"2293_CR28","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10549-014-2896-8","volume":"144","author":"AC Degnim","year":"2014","unstructured":"Degnim AC, Brahmbhatt RD, Radisky DC, Hoskin TL, Stallings-Mann M, Laudenschlager M, Mansfield A, Frost MH, Murphy L, Knutson K, et al. Immune cell quantitation in normal breast tissue lobules with and without lobulitis. Breast Cancer Res Treat. 2014;144:539\u201349.","journal-title":"Breast Cancer Res Treat"},{"key":"2293_CR29","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10549-017-4558-0","volume":"167","author":"D Kerekes","year":"2018","unstructured":"Kerekes D, Visscher DW, Hoskin TL, Radisky DC, Brahmbhatt RD, Pena A, Frost MH, Arshad M, Stallings-Mann M, Winham SJ, et al. CD56\u2009+\u2009immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes. Breast Cancer Res Treat. 2018;167:649\u201358.","journal-title":"Breast Cancer Res Treat"},{"key":"2293_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10549-022-06786-y","volume":"197","author":"J Ogony","year":"2023","unstructured":"Ogony J, Hoskin TL, Stallings-Mann M, Winham S, Brahmbhatt R, Arshad MA, Kannan N, Pena A, Allers T, Brown A, et al. Immune cells are increased in normal breast tissues of BRCA1\/2 mutation carriers. Breast Cancer Res Treat. 2023;197:277\u201385.","journal-title":"Breast Cancer Res Treat"},{"key":"2293_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12920-021-01032-8","volume":"14","author":"SJ Winham","year":"2021","unstructured":"Winham SJ, Wang C, Heinzen EP, Bhagwate A, Liu Y, McDonough SJ, Stallings-Mann ML, Frost MH, Vierkant RA, Denison LA, et al. Somatic mutations in benign breast disease tissues and association with breast cancer risk. BMC Med Genomics. 2021;14:185.","journal-title":"BMC Med Genomics"},{"key":"2293_CR32","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/path.5902","volume":"257","author":"E Gadaleta","year":"2022","unstructured":"Gadaleta E, Thorn GJ, Ross-Adams H, Jones LJ, Chelala C. Field cancerization in breast cancer. J Pathol. 2022;257:561\u201374.","journal-title":"J Pathol"},{"key":"2293_CR33","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10549-017-4441-z","volume":"166","author":"SJ Winham","year":"2017","unstructured":"Winham SJ, Mehner C, Heinzen EP, Broderick BT, Stallings-Mann M, Nassar A, Vierkant RA, Hoskin TL, Frank RD, Wang C, et al. NanoString-based breast cancer risk prediction for women with sclerosing adenosis. Breast Cancer Res Treat. 2017;166:641\u201350.","journal-title":"Breast Cancer Res Treat"},{"key":"2293_CR34","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nbt1385","volume":"26","author":"GK Geiss","year":"2008","unstructured":"Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, Fell HP, Ferree S, George RD, Grogan T, et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol. 2008;26:317\u201325.","journal-title":"Nat Biotechnol"},{"key":"2293_CR35","doi-asserted-by":"crossref","unstructured":"Kulkarni MM. Digital multiplexed gene expression analysis using the NanoString nCounter system. Curr Protoc Mol Biol 2011, Chap. 25:Unit25B 10.","DOI":"10.1002\/0471142727.mb25b10s94"},{"key":"2293_CR36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12957-022-02767-z","volume":"20","author":"D Dong","year":"2022","unstructured":"Dong D, Wang W, Wang H, Chen L, Liu T. The expression pattern of immune-related genes and characterization of tumor immune microenvironment: predicting prognosis and immunotherapeutic effects in cutaneous melanoma. World J Surg Oncol. 2022;20:303.","journal-title":"World J Surg Oncol"},{"key":"2293_CR37","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1111\/1759-7714.14997","volume":"14","author":"JC Guo","year":"2023","unstructured":"Guo JC, Hsu CL, Hsieh MS, Lin CC, Huang TC, Kuo HY, Shao YY, Hsu CH. Different immune contextures underlie tumor site-specific responses to immune checkpoint blockade in esophageal cancer. Thorac Cancer. 2023;14:2216\u201321.","journal-title":"Thorac Cancer"},{"key":"2293_CR38","doi-asserted-by":"crossref","unstructured":"Schroeder BA, Zhang Y, Smythe KS, Desai P, Thomas A, Viveiros P, Alexiev BA, Obeidin F, Chen EY, Cranmer LD et al. Immunologic Gene Signature Analysis Correlates Myeloid Cells and M2 Macrophages with Time to Trabectedin Failure in Sarcoma Patients. Cancers (Basel) 2022, 14.","DOI":"10.3390\/cancers14051290"},{"key":"2293_CR39","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1158\/2326-6066.CIR-18-0277","volume":"6","author":"JA Trujillo","year":"2018","unstructured":"Trujillo JA, Sweis RF, Bao R, Luke JJ. T Cell-Inflamed versus Non-T Cell-Inflamed tumors: a conceptual framework for cancer immunotherapy drug development and combination therapy selection. Cancer Immunol Res. 2018;6:990\u20131000.","journal-title":"Cancer Immunol Res"},{"key":"2293_CR40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.canlet.2016.09.001","volume":"382","author":"D Jia","year":"2016","unstructured":"Jia D, Liu Z, Deng N, Tan TZ, Huang RY, Taylor-Harding B, Cheon DJ, Lawrenson K, Wiedemeyer WR, Walts AE, et al. A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets. Cancer Lett. 2016;382:203\u201314.","journal-title":"Cancer Lett"},{"key":"2293_CR41","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.ccell.2024.08.020","volume":"42","author":"Y Gao","year":"2024","unstructured":"Gao Y, Li J, Cheng W, Diao T, Liu H, Bo Y, Liu C, Zhou W, Chen M, Zhang Y, et al. Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation. Cancer Cell. 2024;42:1764\u2013e17831710.","journal-title":"Cancer Cell"},{"key":"2293_CR42","doi-asserted-by":"publisher","first-page":"217180","DOI":"10.1016\/j.canlet.2024.217180","volume":"600","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Ding L, Li J, Liu K, Xia C, Chen S, Huang X, Pu Y, Song Y, Hu Q, et al. Single-cell RNA sequencing of OSCC primary tumors and lymph nodes reveals distinct origin and phenotype of fibroblasts. Cancer Lett. 2024;600:217180.","journal-title":"Cancer Lett"},{"key":"2293_CR43","doi-asserted-by":"publisher","first-page":"11982","DOI":"10.1073\/pnas.1300136110","volume":"110","author":"MJ Gerdes","year":"2013","unstructured":"Gerdes MJ, Sevinsky CJ, Sood A, Adak S, Bello MO, Bordwell A, Can A, Corwin A, Dinn S, Filkins RJ, et al. Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue. Proc Natl Acad Sci U S A. 2013;110:11982\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2293_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41523-025-00728-9","volume":"11","author":"H Liang","year":"2025","unstructured":"Liang H, Huang J, Li H, He W, Ao X, Xie Z, Chen Y, Lv Z, Zhang L, Zhong Y, et al. Spatial proximity of CD8(+) T cells to tumor cells predicts neoadjuvant therapy efficacy in breast cancer. NPJ Breast Cancer. 2025;11:13.","journal-title":"NPJ Breast Cancer"},{"key":"2293_CR45","doi-asserted-by":"publisher","first-page":"1659093","DOI":"10.1080\/2162402X.2019.1659093","volume":"9","author":"TN Gide","year":"2020","unstructured":"Gide TN, Silva IP, Quek C, Ahmed T, Menzies AM, Carlino MS, Saw RPM, Thompson JF, Batten M, Long GV, et al. Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients. Oncoimmunology. 2020;9:1659093.","journal-title":"Oncoimmunology"},{"key":"2293_CR46","doi-asserted-by":"publisher","first-page":"15095","DOI":"10.1038\/ncomms15095","volume":"8","author":"JL Carstens","year":"2017","unstructured":"Carstens JL, Correa de Sampaio P, Yang D, Barua S, Wang H, Rao A, Allison JP, LeBleu VS, Kalluri R. Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer. Nat Commun. 2017;8:15095.","journal-title":"Nat Commun"},{"key":"2293_CR47","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1245\/s10434-019-07508-3","volume":"26","author":"J Lazarus","year":"2019","unstructured":"Lazarus J, Oneka MD, Barua S, Maj T, Lanfranca MP, Delrosario L, Sun L, Smith JJ, D\u2019Angelica MI, Shia J, et al. Mathematical modeling of the metastatic colorectal cancer microenvironment defines the importance of cytotoxic lymphocyte infiltration and presence of PD-L1 on antigen presenting cells. Ann Surg Oncol. 2019;26:2821\u201330.","journal-title":"Ann Surg Oncol"},{"key":"2293_CR48","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/onc.2011.252","volume":"31","author":"B Huang","year":"2012","unstructured":"Huang B, Qu Z, Ong CW, Tsang YH, Xiao G, Shapiro D, Salto-Tellez M, Ito K, Ito Y, Chen LF. RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor alpha. Oncogene. 2012;31:527\u201334.","journal-title":"Oncogene"},{"key":"2293_CR49","first-page":"131","volume":"1855","author":"J Lotem","year":"2015","unstructured":"Lotem J, Levanon D, Negreanu V, Bauer O, Hantisteanu S, Dicken J, Groner Y. Runx3 at the interface of immunity, inflammation and cancer. Biochim Biophys Acta. 2015;1855:131\u201343.","journal-title":"Biochim Biophys Acta"},{"key":"2293_CR50","doi-asserted-by":"publisher","first-page":"174","DOI":"10.5483\/BMBRep.2018.51.4.033","volume":"51","author":"S Manandhar","year":"2018","unstructured":"Manandhar S, Lee YM. Emerging role of RUNX3 in the regulation of tumor microenvironment. BMB Rep. 2018;51:174\u201381.","journal-title":"BMB Rep"},{"key":"2293_CR51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13058-021-01395-x","volume":"23","author":"TE Rohan","year":"2021","unstructured":"Rohan TE, Arthur R, Wang Y, Weinmann S, Ginsberg M, Loi S, Salgado R. Infiltrating immune cells in benign breast disease and risk of subsequent invasive breast cancer. Breast Cancer Res. 2021;23:15.","journal-title":"Breast Cancer Res"},{"key":"2293_CR52","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/jcb.24074","volume":"113","author":"LF Chen","year":"2012","unstructured":"Chen LF. Tumor suppressor function of RUNX3 in breast cancer. J Cell Biochem. 2012;113:1470\u20137.","journal-title":"J Cell Biochem"},{"key":"2293_CR53","doi-asserted-by":"crossref","unstructured":"Chuang LSH, Matsuo J, Douchi D, Bte Mawan NA, Ito Y. RUNX3 in Stem Cell and Cancer Biology. Cells 2023, 12.","DOI":"10.3390\/cells12030408"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02293-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02293-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02293-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:04:01Z","timestamp":1782101041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02293-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2293"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02293-w","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted under the approval of the Mayo Clinic Institutional Review Board (IRB #75\u201387). All participants provided written informed consent prior to enrollment. Use of archived benign breast tissue and linkage to clinical outcomes were conducted in accordance with institutional policies and the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript does not contain any individual person\u2019s data (including images or videos) that require explicit consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}